School of Optometry

Home | About Us | What's New | Subscribe eNewsletter | 繁體 | 简体 | Graphic

Prospective Students | Current Students | Patients | Profession | Alumni

Mr Samuel ABOKYI | Ms Jingfang Jennifer BIAN | Mr Shashi Kant CHAUDHARY | Mr Ka Wai Jimmy CHEUNG | Mr Kai Yip CHOI | Mr Byung Soo Jeremy KANG | Ms Yamunadevi LAKSHMANAN | Ms Hang I Christie LAM | Mr Ki Kit LAU | Ms Hoi Lam LI | Ms Sonal Aswin VYAS | Mr Kin Ken WAN | Mr Hu XIAO | Ms Biyue GUO | Ms Li PAN | Ms Qi TAN | Mr Mezbah UDDIN | Ms Meng CHENG | Mr Bing Yuan KONG | Ms Rong LI | Ms Yuanyuan LIANG | Ms Anqi LYU | Mr Ying Hon SZE | Ms Qin WANG | Ms Seema BANERJEE | Ms Hangyu ZHANG | Ms Wei YANG | Ms Mei ZHAO | Ms Yajing YANG | Ms Fangyu XU | Mr Sung Hei Jimmy TSE

About us > Our People > Research Students > Ms Qi TAN




ORCiD 0000-0002-2694-3125

Title of project:
Combined atropine with orthokeratology in childhood myopia control (AOK) - A randomized controlled trial

Both orthokeratology (ortho-k) and atropine have been demonstrated to be effective in slowing myopic progression in children. Ortho-k has been shown to slow myopia progression by 40-50%. Although 1% atropine has been shown to be relatively more effective in slowing myopia progression, the treatment results in significant side-effects. A 0.01% concentration atropine, however, has almost negligible side effects and most patients can tolerate the treatment well. The mechanisms of both atropine and ortho-k in slowing myopia are not clearly understood but they exert their effects via different pathways. The aim of this study is to investigate if there is an additional effect on retardation of myopia progression by using a combined 0.01% atropine and ortho-k versus ortho-k alone treatment. This study is a collaboration between the School of Optometry of The Hong Kong Polytechnic University (PolyU) and Department of Ophthalmology of The University of Hong Kong.


Back | Back to Top

Prospective Students | Current Students | Patients | Profession | Alumni